Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

People with alopecia areata have a higher risk of stroke.

COVID-19 increased alopecia areata relapses due to inflammation and stress.

Korean Red Ginseng may help improve hair regrowth when used with corticosteroid injections for Alopecia Areata.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Alopecia areata involves immune response and gene changes affecting hair loss.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Severe pediatric alopecia areata worsens quality of life for patients and families.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

Alopecia areata can look like frontal fibrosing alopecia, making diagnosis hard.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.